Plasma exchange combined with Ofatumumab in the treatment of optic neuromyelitis spectrum diseases, a multicenter randomized controlled study (ChiCTR) - Oct 16, 2026 - P=N/A | N=20 | Recruiting | Sponsor: Renji Hospital, School of Medicine, Shanghai Jiao Tong University; Renji Hospital, School of Medicine, Shanghai Jiao Tong University
New trial • CNS Disorders • Neuromyelitis Optica Spectrum Disorder • Rare Diseases
|